Chapter review

Fitzgerald PMHNP board review. ch12. Personality Disorders. This is drive 6 of 8. When I say Pause. Answer. wait, then I will give the answer. New section. Psychotherapy Modalities and Strategies. Topic. Schema Therapy (ST) and DDP. Chapter Bottom Line. * **General population prevalence**: Personality disorders affect 10% to 20% of the general population and up to 50% of psychiatric clinical populations. * **Heritability and genetics**: **Borderline personality disorder** is 5 times more common among first degree biological relatives. Monozygotic twin studies demonstrate significantly higher concordance rates even when reared apart. * **General diagnostic criteria**: Requires an enduring, inflexible pattern of inner experience and behavior deviating from cultural norms, with onset in adolescence or early adulthood. Must manifest in at least 2 of 4 domains: cognitive capacity, affectivity, interpersonal functioning, and impulse control. * **First-line psychotherapy**: Psychotherapy is the primary treatment of choice for **borderline personality disorder**. **Dialectical behavior therapy** (DBT) is the evidence-based standard. * **First-line pharmacotherapy**: Pharmacotherapy in personality disorders is adjunctive. Target comorbid conditions using SSRIs such as **sertraline** for mood or anxiety symptoms lasting 1 month or longer. Antipsychotics such as low-dose **risperidone** or **olanzapine** can be used for brief psychotic episodes, severe agitation, or transient impulsivity. * **Psychodynamic drivers**: **Splitting** (inability to integrate positive and negative aspects of self or others) and failure to achieve **object constancy** (inability to maintain a relationship or internal image during separation or stress) drive the core pathology of **borderline personality disorder**. * **Therapeutic structure**: The essential **first-line** step in managing **borderline personality disorder** is setting clear limits and defining professional roles using a firm, non-punitive approach. High-Yield Concept Map: Psychotherapy Modalities and Strategies in Personality Disorders. Dialectical Behavior Therapy (DBT). * **What it is**: Evidence-based psychotherapy developed by Marsha Linehan specifically designed for **borderline personality disorder**. * **Why boards care**: It is the gold-standard, evidence-based treatment of choice tested on ANCC and AANPCB exams for reducing parasuicidal behavior, self-harm, and emergency department visits. * **Must know criteria and features**: Integrates mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness. * **First-line**: **First-line** psychotherapy for **borderline personality disorder**. * **Safety alert**: Parasuicidal gestures, cutting, and self-destructive acts require clear safety contracts and outpatient skill application before acute hospitalization. Behavioral Therapy and Social Skills Training. * **What it is**: Structured behavioral interventions used to control emotional outbursts, reduce sensitivity to criticism, and improve interpersonal interactions. * **Why boards care**: Helps patients recognize how maladaptive behaviors impact others and builds external coping mechanisms. * **First-line**: Indicated for Cluster B impulse control issues and Cluster C social inhibition or avoidant behaviors. * **Board trap**: Expecting behavioral therapy to instantly resolve deep-seated personality traits. It targets specific actions and skill building. Insight-Oriented and Psychoanalytic Therapy. * **What it is**: Individual or group therapy focused on uncovering unconscious conflicts, clarifying inner feelings, and developing self-reliance. * **Why boards care**: Indicated for **dependent personality disorder** to foster independence and **histrionic personality disorder** to clarify inner feelings. * **Board trap**: In **dependent personality disorder**, as the patient develops greater independence, anxiety sharply increases due to perceived threat to an important relationship. Monitor anxiety closely during life transitions. Schema Therapy (ST) and Dynamic Deconstructive Psychotherapy (DDP) Context. * **What it is**: Advanced specialized modalities that target early maladaptive schemas and emotional processing in complex personality pathology. * **Why boards care**: While recognized in advanced psychiatric literature, Fitzgerald board review emphasizes **dialectical behavior therapy** (DBT), limit setting, and object relations psychodynamics (**splitting** and **object constancy**) as the primary tested frameworks. Object Relations and Psychodynamic Concepts. * **Splitting**: Primitive defense mechanism where a patient cannot integrate positive and negative qualities of self or others, viewing people as all good or all bad. * **Board trap**: Patients with **borderline personality disorder** frequently split clinic staff (for example, idealizing the PMHNP while abusing front-desk administrative staff). * **First-line approach**: Maintain clear staff communication, enforce consistent boundaries across the entire care team, and require the patient to address inappropriate behavior directly. * **Object Constancy**: The developmental ability to maintain a stable, positive emotional connection to a significant other even during physical absence or intense conflict. * **Safety alert**: Lack of object constancy in **borderline personality disorder** triggers intense rage, fears of abandonment, and destructive behaviors when a partner or provider is temporarily away. Compare and Distinguish: Psychotherapy Matching Across Clusters. Cluster A (Paranoid, Schizoid, Schizotypal). * **Primary approach**: Straightforward, warm, honest, and non-judgmental stance. * **Priority**: Respect distance and avoid forced intimacy, as trust is a major barrier. Use a non-judgmental approach if odd fantasies or thoughts are shared. * **Pharmacotherapy**: Low-dose second-generation antipsychotics like **risperidone** for ideas of reference, transient illusions, or severe agitation. Cluster B (Antisocial, Borderline, Histrionic, Narcissistic). * **Primary approach**: **Dialectical behavior therapy** for **borderline personality disorder**; clear limit setting and defined roles for **antisocial personality disorder**; group therapy for **narcissistic personality disorder** to increase empathy. * **First-line**: Psychotherapy is primary. Adjunctive SSRIs like **sertraline** for co-occurring **major depressive disorder** or anxiety. * **Board trap**: Prescribing benzodiazepines or stimulants without caution. Avoid routine use due to high rates of co-occurring substance use disorders and disinhibition risks. Cluster C (Avoidant, Dependent, Obsessive-Compulsive). * **Primary approach**: Assertiveness training and behavioral skill building for **avoidant personality disorder**; insight-oriented therapy for **dependent personality disorder**; behavioral and group therapy for **obsessive-compulsive personality disorder**. * **Priority**: Encourage autonomy while monitoring for spikes in anxiety when dependent relationships are challenged. Practice Question Bank. Question 1. Match the personality disorder symptom to the corresponding diagnosis: 1. No conscience and no remorse 2. Suspicious of others' motives 3. Need for admiration and lacks empathy 4. Unstable interpersonal relationships, self-image, and impulsivity 5. Excessive emotionality and attention seeking 6. Submissive, fear of separation, and clinging behavior 7. Detached from social relationships and restricted emotional expression Options: A. **Antisocial personality disorder** B. **Borderline personality disorder** C. **Dependent personality disorder** D. **Histrionic personality disorder** E. **Narcissistic personality disorder** F. **Paranoid personality disorder** G. **Schizoid personality disorder** Pause. Answer: 1 matches A (**Antisocial personality disorder**) 2 matches F (**Paranoid personality disorder**) 3 matches E (**Narcissistic personality disorder**) 4 matches B (**Borderline personality disorder**) 5 matches D (**Histrionic personality disorder**) 6 matches C (**Dependent personality disorder**) 7 matches G (**Schizoid personality disorder**) Why correct: * Item 1: Lack of remorse and disregard for rights defines **antisocial personality disorder**. * Item 2: Pervasive distrust and interpreting motives as malevolent defines **paranoid personality disorder**. * Item 3: Grandiosity, need for admiration, and lack of empathy defines **narcissistic personality disorder**. * Item 4: Instability of relationships, self-image, affect, and marked impulsivity defines **borderline personality disorder**. * Item 5: Excessive emotionality and attention-seeking behavior defines **histrionic personality disorder**. * Item 6: Submissive and clinging behavior with intense fears of separation defines **dependent personality disorder**. * Item 7: Social detachment and restricted emotional range defines **schizoid personality disorder**. Question 2. Which of the following is not a Cluster B personality disorder? A. **Borderline** B. **Obsessive-compulsive** C. **Antisocial** D. **Histrionic** Pause. Answer: B Why correct: **Obsessive-compulsive personality disorder** belongs to Cluster C (anxious and fearful disorders). Why the other choices are wrong: * A: **Borderline personality disorder** is a Cluster B (dramatic, emotional, erratic) disorder. * C: **Antisocial personality disorder** is a Cluster B disorder. * D: **Histrionic personality disorder** is a Cluster B disorder. Question 3. Cluster A disorders are best characterized as: A. Odd, eccentric, aloof disorders B. Dramatic, emotional, erratic disorders C. Anxious and fearful disorders D. Violent and aggressive disorders Pause. Answer: A Why correct: Cluster A includes **paranoid**, **schizoid**, and **schizotypal** personality disorders, which are characterized as odd, eccentric, or aloof. Why the other choices are wrong: * B: Describes Cluster B personality disorders. * C: Describes Cluster C personality disorders. * D: Is not a recognized DSM cluster description. Question 4. Emil is a 34-year-old married physician you see approximately monthly for counseling related to various work and relationship issues. He is diagnosed with Cluster B traits. He recently presented with a one-month history of symptoms consistent with **major depressive disorder**. An appropriate first-line psychotropic agent would be: A. **Quetiapine** B. **Lithium** C. **Sertraline** D. **Amitriptyline** Pause. Answer: C Why correct: **Sertraline** is an SSRI and represents the **first-line** pharmacotherapy choice for co-occurring **major depressive disorder** in a patient with Cluster B personality traits. Why the other choices are wrong: * A: **Quetiapine** is a second-generation antipsychotic used as an adjunct or for psychosis, not first-line antidepressant monotherapy. * B: **Lithium** is a mood stabilizer for bipolar disorder and is not indicated as first-line monotherapy for unipolar depression. * D: **Amitriptyline** is a tricyclic antidepressant associated with severe anticholinergic side effects and lethal overdose risk. Question 5. You are interviewing Audriana, a 34-year-old married mother of two who has feelings of depression. As the interview progresses, you become concerned that **borderline personality disorder** is a possible diagnosis and you ask more focused questions. Which of the following statements is least likely to be characteristic of a statement made by a person with **borderline personality disorder**? A. I kicked my husband out of the house last week, but then ten minutes later I was driving around frantic to find him. B. I don't have many girlfriends. I think women are so catty and critical and they talk about their problems all the time. C. The therapist who referred me to you told me you were excellent, and I agreed you are the best listener. D. I left the party after about 20 minutes. Not one person had commented on my 10-pound weight loss and new dress. Pause. Answer: D Why correct: Statement D focuses on excessive need for attention regarding physical appearance, which is characteristic of **histrionic personality disorder** rather than **borderline personality disorder**. Why the other choices are wrong: * A: Illustrates rapid shifts between abandonment fears, anger, and desperate clinging typical of **borderline personality disorder**. * B: Reflects **splitting** and externalizing interpersonal conflict common in **borderline personality disorder**. * C: Reflects rapid idealization of a new care provider, an example of **splitting** seen in **borderline personality disorder**. Question 6. Jamie is a 27-year-old single mother who is being seen every two weeks for counseling regarding **borderline personality disorder**. She describes an episode last week when her significant other left for a trip for a few days, and she became enraged when he did not call one night, fearing that he will not return. In her rage, she destroyed most of his belongings. The PMHNP recognizes that this behavior likely stems from which of the following? A. Dual diagnosis with **major depressive disorder** B. Late onset of personality disorder C. Inability to attain object constancy D. Cluster A traits Pause. Answer: C Why correct: Failure to achieve **object constancy** leaves the patient unable to maintain an internal sense of security or mental image of a partner during absence, triggering acute rage and fears of abandonment. Why the other choices are wrong: * A: Major depression does not cause acute separation-induced rage and destruction of property. * B: Personality disorders emerge in adolescence or early adulthood, and this presentation reflects core BPD psychodynamics. * D: Object constancy deficits and intense affective rage belong to Cluster B, not Cluster A. Question 7. When initiating psychotherapy for a patient with **borderline personality disorder**, an important first step in establishing the therapist-patient relationship is: A. Developing a system of rewards and punishment B. Setting limits and defining roles C. Involving close family and friends in the first few sessions D. Discontinuing psychopharmacotherapy Pause. Answer: B Why correct: Setting clear limits, defining roles, and establishing firm boundaries is the critical **first-line** structural intervention required when initiating therapy with a patient diagnosed with **borderline personality disorder**. Why the other choices are wrong: * A: Punitive or reward-based systems damage the therapeutic alliance and are counter-therapeutic. * C: Involving family initially can compound **splitting** dynamics and interfere with establishing an individual therapeutic alliance. * D: Discontinuing helpful adjunctive medications is unnecessary and potentially harmful to symptom stabilization. Active Recall Checkpoints. 1. What is the estimated prevalence of personality disorders in the general population versus psychiatric clinical settings? 2. How much higher is the risk of **borderline personality disorder** among first degree biological relatives? 3. What are the four core domain categories used in the general diagnostic criteria for a personality disorder? 4. What is the evidence-based psychotherapy of choice for **borderline personality disorder**, and who developed it? 5. How does the defense mechanism of **splitting** manifest in a clinical practice setting? 6. Define **object constancy** and explain what happens when a patient with **borderline personality disorder** lacks it. 7. What is the essential **first-line** structural step when initiating psychotherapy for a patient with **borderline personality disorder** or **antisocial personality disorder**? Next Study Step. Study Fitzgerald Chapter 13: Suicide, Violence, and Crisis Management. * **Why this is the best next step**: Builds directly on Cluster B impulse control, self-destructive risk, and safety planning strategies. * **What knowledge gap it closes**: Bridges personality pathology with acute safety assessment, lethality evaluation, and crisis stabilization rules on board exams. Next. Topic. Practice Question Q7: First Psychotherapy Step. Bottom Line Summary. * **Prevalence and Genetics**: Personality disorders occur in 10% to 20% of the general population and up to 50% of psychiatric inpatients. **Borderline personality disorder** is 5 times more common among first-degree biological relatives of individuals with the disorder. * **General Diagnostic Criteria**: DSM-5-TR criteria require an enduring, inflexible pattern of inner experience and behavior that deviates markedly from cultural expectations, causing impairment across at least 2 of 4 domains: cognitive capacity, affectivity, interpersonal functioning, and impulse control. * **Primary Treatment Modality**: Psychotherapy is the principal treatment of choice for **borderline personality disorder**. **Dialectical behavior therapy** (**DBT**) is the gold-standard evidence-based model. Psychopharmacotherapy is strictly adjunctive. * **Essential Initial Clinical Step**: Initiating psychotherapy in **borderline personality disorder** requires setting clear limits and defining clinical roles using a firm, warm, non-punitive approach. * **Core Psychodynamic Defenses**: Key features include **splitting** (the inability to integrate positive and negative qualities of self or others) and lack of **object constancy** (the inability to maintain emotional attachment during separation or stress). * **First-line Adjunctive Pharmacotherapy**: **SSRIs** treat comorbid depressive or anxiety symptoms. Low-dose antipsychotics treat transient psychosis, severe agitation, or impulsivity. * **Safety alert**: Avoid **benzodiazepines** in Cluster B personality disorders due to high risk of disinhibition, overdose, and co-occurring **substance use disorder**. Clinical Teaching and High-Yield Concepts. Core Therapeutic Principles. * **First-line** modality: Psychotherapy takes precedence over pharmacotherapy in managing **borderline personality disorder**. Medications only manage target symptoms or comorbid disorders. * **Safety alert**: Unclear clinical boundaries lead to boundary testing, staff splitting, and treatment failure. Clinicians must establish clear parameters regarding appointment times, contact between sessions, and therapeutic expectations. * **Board trap**: Believing that setting limits is punitive or damages rapport. On national certification exams, setting firm boundaries is recognized as the essential foundational step for patient safety and therapeutic alliance. Spoken Grouping of Treatment Strategies. * **Cluster A Strategies**: Approach paranoid, schizoid, and schizotypal patients in a straightforward, warm, and honest fashion. Respect their wariness, avoid forcing premature closeness, and maintain a non-judgmental stance toward odd thoughts or fantasies. * **Cluster B Strategies**: Set firm limits from the beginning for antisocial and borderline presentations. Use **DBT** to build distress tolerance, emotional regulation, and mindfulness. Use group therapy for histrionic and narcissistic presentations to build empathy and reduce attention seeking. * **Cluster C Strategies**: Use supportive, insight-oriented, and behavioral therapies. For avoidant patterns, incorporate assertiveness training. For dependent patterns, encourage self-reliance while monitoring for elevated anxiety when independence threatens key relationships. Sample Practice Question. Question 7. When initiating psychotherapy for a patient with **borderline personality disorder**, an important **first** step in establishing the therapist-patient relationship is: * A. Developing a system of rewards and punishment * B. Setting limits and defining roles * C. Involving close family and friends in the first few sessions * D. Discontinuing psychopharmacotherapy Pause. Answer. B. Rationale and Distractor Analysis. Quick Answer. The best answer is B, setting limits and defining roles. Key Clue. The phrase **first** step when initiating psychotherapy for a patient with **borderline personality disorder**. Best Answer. B. Setting limits and defining roles Why It Is Correct. Patients with **borderline personality disorder** present with profound interpersonal instability, fear of abandonment, and primitive defense mechanisms like **splitting**. Establishing clear clinical limits and role expectations at the outset creates a safe, structured environment. This firm but non-punitive framework prevents boundary confusion and protects both the patient and the PMHNP. Why the Other Choices Are Wrong. * **A**: A system of rewards and punishment represents rigid operant conditioning that creates power struggles, damages therapeutic trust, and fails to establish clear relational boundaries. * **B**: This is the correct choice. * **C**: Involving close family or friends in initial individual sessions disrupts boundary setting, complicates rapport building, and can trigger intense interpersonal conflict or fears of abandonment. * **D**: Discontinuing psychopharmacotherapy is unsafe because psychotropic medications serve as valuable adjunctive tools for treating comorbid **major depressive disorder**, anxiety, or severe affective dysregulation. Test-Taking Pearl. When treating Cluster B personality disorders on board exams, prioritize establishing clear boundaries and safety limits **first** before attempting deep exploratory therapy or altering medication regimens. 💡 **Next Study Step**: Practice contrasting **splitting** versus **projection**, or review the specific **DBT** skill modules (**mindfulness**, **distress tolerance**, **emotion regulation**, **interpersonal effectiveness**) frequently tested on ANCC/AANPCB exams. Next. New section. Pharmacotherapy and Board Traps. Topic. Medication Target Symptoms. Bottom Line Summary. * **Psychotherapy is primary**: Psychotherapy, such as **dialectical behavior therapy**, is the primary treatment of choice for personality disorders. Pharmacotherapy is strictly adjunctive and targets specific symptom clusters or comorbid conditions rather than curing the underlying personality structure. * **Epidemiology and genetics**: Personality disorders occur in 10% to 20% of the general population and up to 50% of psychiatric patients. **Borderline personality disorder** is 5 times more common in first-degree biological relatives, and **schizotypal personality disorder** is more common in relatives of individuals with **schizophrenia**. * **First-line for mood and anxiety**: **First-line** pharmacotherapy for comorbid **major depressive disorder** or anxiety in patients with personality disorders is an **SSRI** such as **sertraline**. * **Affective dysregulation and impulsivity**: Mood stabilizers like **lithium** or **valproate**, as well as **omega-3 fatty acids**, serve as target treatments for mood lability, hostility, and behavioral impulsivity. * **Cognitive-perceptual symptoms**: Atypical antipsychotics such as low-dose **risperidone** or **quetiapine** target brief psychotic episodes, ideas of reference, illusions, and severe agitation. * **Safety alert for controlled substances**: Avoid routine use of **benzodiazepines** or **stimulants** without strict screening, because personality disorders carry a high rate of comorbid **substance use disorder** and risk of disinhibition. High-Yield Concept Map: Pharmacotherapy and Target Symptoms. Treatment Overview. * **Primary modality**: Psychotherapy remains the core evidence-based intervention across all personality disorder clusters. * **Adjunctive role of medication**: Psychotropic medications do not alter core personality traits. They are prescribed solely to manage specific target symptom domains or comorbid axis disorders. * **Diagnostic threshold**: General criteria require an enduring, inflexible pattern causing impairment in at least 2 domains: cognition, affectivity, interpersonal functioning, or impulse control. Target Symptom Domains and Drug Selection. * **Comorbid depression and anxiety**: * **First-line**: **SSRIs** like **sertraline** or **fluoxetine** are indicated when patients present with comorbid **major depressive disorder** or persistent anxiety. * **Clinical pearl**: Standard dosing and titration guidelines for primary mood disorders apply when treating comorbid depressive episodes in personality disorders. * **Affective dysregulation and impulse control**: * **First-line**: Mood stabilizers like **lithium** or **valproate** help control emotional lability, irritability, and impulse control deficits. * **Alternative**: **Omega-3 fatty acids** have shown benefit in reducing affect dysregulation and impulsive aggression in **borderline personality disorder**. * **Cognitive-perceptual distortions and brief psychosis**: * **First-line**: Low-dose second-generation antipsychotics like **risperidone** or **quetiapine** are used for ideas of reference, transient paranoia, illusions, and anger outbursts. * **Clinical pearl**: Symptom control often occurs at lower dosages than those required for primary psychotic disorders. High-Yield Clinical Signposts. First-Line. * **First-line psychotherapy**: Psychotherapy (e.g., **DBT** for **borderline personality disorder**) is the **first-line** treatment for overall disorder management. * **First-line pharmacotherapy**: **SSRIs** (e.g., **sertraline**) are **first-line** when treating comorbid **major depressive disorder** or anxiety in patients with Cluster A, B, or C traits. Board Trap. * **The premature antipsychotic or mood stabilizer trap**: Test writers present a patient with Cluster B traits who meets criteria for a 1-month episode of **major depressive disorder**. The trap is selecting **quetiapine** or **lithium** first because of the personality disorder label. The correct board choice is an **SSRI** like **sertraline** to address the major depressive episode. * **The cure expectation trap**: Assuming medication will resolve interpersonal drama or defense mechanisms like **splitting**. Medications target biological symptom domains only. Safety Alert. * **Substance use disorder risk**: Patients with personality disorders have high rates of comorbid **substance use disorder**. Prescribing **benzodiazepines** for anxiety risks dependence, misuse, and paradoxical behavioral disinhibition. * **Tricyclic toxicity**: Avoid tricyclic antidepressants like **amitriptyline** due to fatal overdose potential in patients with suicidal ideation or self-harm behaviors. Target Symptom Comparison. Depressive and Anxiety Symptoms. * **Think**: Persistent low mood, anhedonia, vegetative signs, or pervasive anxiety. * **Priority**: Evaluate for a distinct comorbid mood or anxiety disorder. * **Boards are testing**: Selection of standard first-line **SSRIs** like **sertraline**. Affective Lability and Behavioral Impulsivity. * **Think**: Rapid mood swings, intense anger outbursts, and self-damaging impulsive actions. * **Priority**: Stabilize mood and reduce behavioral dyscontrol. * **Boards are testing**: Use of mood stabilizers (**lithium**, **valproate**) or **omega-3 fatty acids**. Cognitive-Perceptual Distortions. * **Think**: Micro-psychotic episodes, paranoid ideation, illusions, or severe agitation under stress. * **Priority**: Acute symptom reduction and safety. * **Boards are testing**: Low-dose second-generation antipsychotics (**risperidone**, **quetiapine**). Fitzgerald Sample Test Question. Question 1. Emil is a 34-year-old married physician you see approximately monthly for counseling related to various work and relationship issues. He is diagnosed with Cluster B traits. He recently presented with a 1-month history of symptoms consistent with **major depressive disorder**. An appropriate **first-line** psychotropic agent would be: A) Quetiapine B) Lithium C) Sertraline D) Amitriptyline Pause. Answer. Quick Answer. The correct choice is C) Sertraline. Key Clue. The patient presents with a 1-month history of symptoms meeting criteria for **major depressive disorder**, which requires standard **first-line** antidepressant treatment regardless of underlying personality traits. Best Answer. C) Sertraline Why It Is Correct. When a patient with personality disorder traits develops a distinct comorbid episode of **major depressive disorder**, the PMHNP initiates standard **first-line** evidence-based pharmacotherapy. **SSRIs** like **sertraline** are the preferred **first-line** agents due to their efficacy and favorable safety profile. Why the Other Choices Are Wrong. * **A:** Quetiapine is a second-generation antipsychotic and is not **first-line** monotherapy for an uncomplicated initial episode of **major depressive disorder**. * **B:** Lithium is a mood stabilizer primary indicated for bipolar mania and maintenance, not **first-line** for unipolar **major depressive disorder**. * **D:** Amitriptyline is a tricyclic antidepressant reserved for later-line treatment due to anticholinergic side effects and lethal cardiac toxicity in overdose. Test-Taking Pearl. Treat co-occurring primary psychiatric disorders (like **major depressive disorder**) according to national guidelines using standard **first-line** agents like **SSRIs**, without being distracted by underlying personality traits. Active Recall Checkpoints. 1. What is the primary, **first-line** treatment modality for any personality disorder? 2. What drug class is **first-line** when a patient with a personality disorder presents with comorbid **major depressive disorder**? 3. Which target symptom domain in **borderline personality disorder** responds to mood stabilizers or **omega-3 fatty acids**? 4. Which medication class is used for brief psychotic episodes, ideas of reference, or severe agitation in Cluster A or B disorders? 5. Why are **benzodiazepines** generally avoided or used with extreme caution in personality disorders? Next. Topic. Meds to Avoid: Benzodiazepines. Bottom Line Summary. * Approximately 10% to 20% of the general population and up to 50% of psychiatric patients have a **personality disorder**, which frequently co-occurs with other psychiatric conditions. * **Borderline personality disorder** demonstrates a strong genetic component, being 5 times more common among first-degree biological relatives of affected individuals. * **Safety alert**: **Benzodiazepines** are generally avoided in **Cluster B personality disorders** due to a high risk of physiological and psychological dependence, tolerance, and severe behavioral disinhibition that can increase impulsivity, rage outbursts, and self-harm. * **First-line**: When treating co-occurring **major depressive disorder** or anxiety in a patient with **Cluster B** traits, an **SSRI** such as **sertraline** is the **first-line** psychotropic agent. * Low-dose **second-generation antipsychotics** (such as **risperidone** or **quetiapine**) can be used as adjunctive therapy in **Cluster B** to target severe impulsivity, hostility, anger, and brief psychotic episodes. * Psychotherapy is the primary treatment of choice for **personality disorders**, with **dialectical behavior therapy** (**DBT**) serving as the gold-standard evidence-based modality for **borderline personality disorder**. * **Board trap**: Prescribing **benzodiazepines** for acute anxiety in **borderline personality disorder** risks worsening emotional dysregulation, increasing self-destructive behaviors, and precipitating substance misuse. * Diagnostic criteria for a general **personality disorder** require an enduring, inflexible pattern starting by adolescence or early adulthood, causing dysfunction across at least 2 domains: cognition, affectivity, interpersonal functioning, or impulse control. Pharmacotherapy and Board Traps: Meds to Avoid - Benzodiazepines. Clinical Overview of Benzodiazepines in Personality Disorders. * **Pharmacotherapy role**: In **personality disorders**, medication is strictly adjunctive. Psychotherapy is the primary treatment of choice. Medications target specific co-occurring symptoms such as depression, anxiety, or psychosis. * **Safety alert**: **Benzodiazepines** are rarely prescribed and should generally be avoided in **personality disorders**, especially **Cluster B personality disorders** (such as **borderline personality disorder** and **antisocial personality disorder**). * **Dependence and addiction risks**: **Personality disorders** serve as a major predisposing factor for **substance use disorders**. Introducing **benzodiazepines** carries a high risk of physiological tolerance, psychological dependence, abuse, and addiction. * **Behavioral disinhibition**: In patients with **Cluster B** pathology, **benzodiazepines** can lower cognitive control and cause paradoxical behavioral disinhibition. This disinhibition can worsen core deficits in impulse control, leading to escalated anger, violent outbursts, reckless behaviors, and self-destructive or suicidal acts. * **First-line** alternative: For co-occurring anxiety or depressive episodes in **Cluster B**, **SSRIs** (such as **sertraline**) represent the **first-line** intervention. They effectively treat mood and anxiety symptoms without the addiction or disinhibition risks associated with **benzodiazepines**. * **Adjunctive antipsychotic use**: When patients with **borderline personality disorder** exhibit severe impulsivity, hostility, or brief psychotic episodes, low-dose **second-generation antipsychotics** (such as **risperidone** or **quetiapine**) are preferred over **benzodiazepines**. Cluster Classification and Treatment Principles. To synthesize the treatment approach across clusters, compare the primary features, therapeutic approaches, and medication strategies: Cluster A (Odd, Eccentric, Aloof) * Includes **paranoid**, **schizoid**, and **schizotypal** personality disorders. * Therapy approach: Maintain a straightforward, warm, honest, and nonjudgmental stance. Respect distance due to trust issues. * Pharmacotherapy: Low-dose **second-generation antipsychotics** (such as **risperidone**) for ideas of reference, illusions, or quasi-delusional thinking, alongside **SSRIs** for co-occurring depression or anxiety. Cluster B (Dramatic, Emotional, Erratic) * Includes **antisocial**, **borderline**, **histrionic**, and **narcissistic** personality disorders. * Therapy approach: Set clear limits and define clinical roles from the outset. Use **dialectical behavior therapy** (**DBT**) for **borderline personality disorder** to build distress tolerance, emotion regulation, and mindfulness. * Pharmacotherapy: **SSRIs** for mood and anxiety symptoms; low-dose **second-generation antipsychotics** for impulsivity, anger, and brief psychosis. Avoid **benzodiazepines** due to disinhibition and addiction risks. Cluster C (Anxious, Fearful) * Includes **avoidant**, **dependent**, and **obsessive-compulsive** personality disorders. * Therapy approach: Build a supportive relationship, utilize behavioral skill-building, assertiveness training, and cognitive restructuring. Monitor for increased anxiety in **dependent personality disorder** as independence grows. * Pharmacotherapy: **SSRIs** for underlying anxiety and depressive symptoms. Board Traps and Distractor Logic. * **Board trap**: Choosing a **benzodiazepine** to manage acute agitation or anxiety in a patient with **borderline personality disorder**. Test writers expect you to recognize that **benzodiazepines** can cause disinhibition, increase suicide risk, and lead to dependency. * **Board trap**: Selecting **lithium** or tricyclic antidepressants (**amitriptyline**) as **first-line** therapy for depression in **Cluster B**. **SSRIs** (like **sertraline**) are the correct **first-line** choice due to safety and efficacy. * **Board trap**: Relying on medication as the primary cure for a **personality disorder**. Medication only treats comorbid symptoms; psychotherapy (such as **DBT**) is the definitive treatment. * **Board trap**: Failing to set firm clinical boundaries at the initial visit. Setting clear limits and defining roles is essential to prevent **splitting** and maintain a safe therapeutic space. Fitzgerald Sample Test Questions. Question 1. Match the personality disorder symptom to the correct disorder: 1. No conscience and no remorse 2. Suspicious of others' motives 3. Need for admiration and lacks empathy 4. Unstable interpersonal relationships, self-image, and marked impulsivity 5. Excessive emotionality and attention-seeking 6. Submissive, clinging behavior, and fear of separation 7. Detached from social relationships and restricted range of interpersonal affect A) **Antisocial personality disorder** B) **Borderline personality disorder** C) **Dependent personality disorder** D) **Histrionic personality disorder** E) **Narcissistic personality disorder** F) **Paranoid personality disorder** G) **Schizoid personality disorder** Pause. Answer. 1 matches A (**Antisocial personality disorder**). 2 matches F (**Paranoid personality disorder**). 3 matches E (**Narcissistic personality disorder**). 4 matches B (**Borderline personality disorder**). 5 matches D (**Histrionic personality disorder**). 6 matches C (**Dependent personality disorder**). 7 matches G (**Schizoid personality disorder**). Why correct: Each description highlights the cardinal DSM-5-TR diagnostic feature for that specific personality disorder. Why each distractor fails: * Lack of remorse is specific to **antisocial personality disorder**, not other clusters. * Distrust and suspicion define **paranoid personality disorder**. * Grandiose need for admiration defines **narcissistic personality disorder**. * Instability and impulsivity define **borderline personality disorder**. * Attention-seeking defines **histrionic personality disorder**. * Clinging behavior defines **dependent personality disorder**. * Social detachment defines **schizoid personality disorder**. Question 2. Which of the following is not a **Cluster B personality disorder**? A) **Borderline personality disorder** B) **Obsessive-compulsive personality disorder** C) **Antisocial personality disorder** D) **Histrionic personality disorder** Pause. Answer. B. Why correct: **Obsessive-compulsive personality disorder** is categorized under **Cluster C** (the anxious and fearful cluster), not **Cluster B**. Why each distractor fails: * Choice A: **Borderline personality disorder** is a primary **Cluster B** disorder. * Choice C: **Antisocial personality disorder** is a primary **Cluster B** disorder. * Choice D: **Histrionic personality disorder** is a primary **Cluster B** disorder. Question 3. **Cluster A** disorders are best characterized as: A) Odd, eccentric, and aloof disorders B) Dramatic, emotional, and erratic disorders C) Anxious and fearful disorders D) Violent and aggressive disorders Pause. Answer. A. Why correct: **Cluster A** includes **paranoid**, **schizoid**, and **schizotypal** personality disorders, which share the common features of being odd, eccentric, and aloof. Why each distractor fails: * Choice B: Dramatic, emotional, and erratic describes **Cluster B** disorders. * Choice C: Anxious and fearful describes **Cluster C** disorders. * Choice D: Violent and aggressive is not a recognized DSM cluster designation. Question 4. Emil is a 34-year-old married physician you see approximately monthly for counseling related to various work and relationship issues. He is diagnosed with **Cluster B** traits. He recently presented with a 1-month history of symptoms consistent with **major depressive disorder**. An appropriate **first-line** psychotropic agent would be: A) **Quetiapine** B) **Lithium** C) **Sertraline** D) **Amitriptyline** Pause. Answer. C. Why correct: When a patient with **Cluster B** traits develops co-occurring **major depressive disorder**, an **SSRI** such as **sertraline** is the **first-line** pharmacotherapy choice. Why each distractor fails: * Choice A: **Quetiapine** is a **second-generation antipsychotic** and is not **first-line** monotherapy for unipolar depression. * Choice B: **Lithium** is indicated for **bipolar disorder**, not **first-line** for unipolar depression. * Choice D: **Amitriptyline** is a tricyclic antidepressant associated with high anticholinergic burden and lethal toxicity in overdose. Question 5. You are interviewing Audriana, a 34-year-old married mother of two who has feelings of depression. As the interview progresses, you become concerned that **borderline personality disorder** is a possible diagnosis and you ask more focused questions. Which of the following statements is least likely to be characteristic of a statement made by a person with **borderline personality disorder**? A) I kicked my husband out of the house last week, but then 10 minutes later I was driving around, frantic to find him. B) I don't have many girlfriends. I think women are so catty and critical and they talk about their problems all the time. C) I see the therapist who referred me to you told me you were excellent, and I agreed you are the best listener. D) I left the party after about 20 minutes. Not one person had commented on my 10-pound weight loss and new dress. Pause. Answer. D. Why correct: Leaving an event due to lack of compliments on physical appearance demonstrates vanity and attention-seeking characteristic of **histrionic personality disorder**, making it the least likely statement for **borderline personality disorder**. Why each distractor fails: * Choice A: Rapidly rejecting a partner then frantically searching reflects classic fears of abandonment and emotional lability in **borderline personality disorder**. * Choice B: Viewing women as catty and critical reflects **splitting** and impaired relationships in **borderline personality disorder**. * Choice C: Calling the provider "the best listener" reflects the idealization phase of **splitting** in **borderline personality disorder**. Question 6. Jamie is a 27-year-old single mother who is being seen every 2 weeks for counseling regarding **borderline personality disorder**. She describes an episode last week when her significant other left for a trip for a few days, and she became enraged when he did not call one night, fearing that he will not return. In her rage, she destroyed most of his belongings. The PMHNP recognizes that this behavior likely stems from which of the following: A) Dual diagnosis with **major depressive disorder** B) A late onset of personality disorder C) An inability to attain object constancy D) **Cluster A** traits Pause. Answer. C. Why correct: Patients with **borderline personality disorder** lack object constancy, leaving them unable to hold a comforting mental image of an absent partner, which triggers intense separation rage and fear of abandonment. Why each distractor fails: * Choice A: Destruction of property from separation rage is driven by personality structure, not a co-occurring depressive episode. * Choice B: **Personality disorders** manifest by adolescence or early adulthood, not late onset. * Choice D: Impulsive rage and abandonment fears belong to **Cluster B**, not **Cluster A**. Question 7. When initiating psychotherapy for a patient with **borderline personality disorder**, an important first step in establishing the therapist-patient relationship is: A) Developing a system of rewards and punishment B) Setting limits and defining roles C) Involving close family and friends in the first few sessions D) Discontinuing psychopharmacotherapy Pause. Answer. B. Why correct: Setting clear limits and defining clinical roles from the beginning creates a safe framework, prevents **splitting**, and establishes a firm, non-punitive therapeutic alliance. Why each distractor fails: * Choice A: Reward and punishment systems are punitive and damage therapeutic trust. * Choice C: Bringing family into initial individual sessions complicates boundaries and heightens volatility. * Choice D: Stopping adjunctive psychotropic medications is unnecessary and counterproductive when co-occurring conditions exist. 💡 *Next Study Step: Review Fitzgerald Chapter 13 (Suicide, Violence, and Grief) to deepen crisis management and risk assessment frameworks.* Next. End of this drive.